Jan H. Marxsen

1.5k total citations
16 papers, 1.2k citations indexed

About

Jan H. Marxsen is a scholar working on Cancer Research, Molecular Biology and Internal Medicine. According to data from OpenAlex, Jan H. Marxsen has authored 16 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Cancer Research, 6 papers in Molecular Biology and 4 papers in Internal Medicine. Recurrent topics in Jan H. Marxsen's work include Cancer, Hypoxia, and Metabolism (5 papers), Venous Thromboembolism Diagnosis and Management (4 papers) and Cancer Genomics and Diagnostics (3 papers). Jan H. Marxsen is often cited by papers focused on Cancer, Hypoxia, and Metabolism (5 papers), Venous Thromboembolism Diagnosis and Management (4 papers) and Cancer Genomics and Diagnostics (3 papers). Jan H. Marxsen collaborates with scholars based in Germany, Switzerland and Czechia. Jan H. Marxsen's co-authors include Wolfgang Jelkmann, Eric Metzen, Thomas Hellwig‐Bürgel, Thomas M. Wagner, Panu Jaakkola, Terhi Jokilehto, Pekka T. Heikkinen, Holger Kalthoff, B. Kremer and Doris Henne‐Bruns and has published in prestigious journals such as Biochemical Journal, Journal of Cell Science and British Journal of Cancer.

In The Last Decade

Jan H. Marxsen

15 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jan H. Marxsen Germany 11 796 582 275 227 137 16 1.2k
Jennifer A. Doll United States 21 371 0.5× 921 1.6× 363 1.3× 192 0.8× 108 0.8× 29 1.6k
Colleen Wu United States 12 535 0.7× 675 1.2× 469 1.7× 115 0.5× 145 1.1× 19 1.3k
Xianguo Kong United States 16 824 1.0× 1.0k 1.8× 255 0.9× 106 0.5× 97 0.7× 25 1.7k
Betty Gardie France 15 516 0.6× 803 1.4× 194 0.7× 135 0.6× 178 1.3× 36 1.3k
Xiao-Ping Zhou United States 14 325 0.4× 1.1k 1.9× 306 1.1× 179 0.8× 104 0.8× 17 1.4k
Françoise Descôtes France 20 326 0.4× 593 1.0× 342 1.2× 119 0.5× 53 0.4× 66 1.2k
Michael Fannon United States 13 273 0.3× 809 1.4× 276 1.0× 76 0.3× 85 0.6× 22 1.3k
Cara C. Bertozzi United States 6 237 0.3× 479 0.8× 337 1.2× 104 0.5× 133 1.0× 8 958
Thomas Haberberger United States 7 418 0.5× 486 0.8× 53 0.2× 172 0.8× 102 0.7× 8 844
Ariane Galaup France 15 372 0.5× 667 1.1× 148 0.5× 68 0.3× 105 0.8× 17 1.3k

Countries citing papers authored by Jan H. Marxsen

Since Specialization
Citations

This map shows the geographic impact of Jan H. Marxsen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan H. Marxsen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan H. Marxsen more than expected).

Fields of papers citing papers by Jan H. Marxsen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan H. Marxsen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan H. Marxsen. The network helps show where Jan H. Marxsen may publish in the future.

Co-authorship network of co-authors of Jan H. Marxsen

This figure shows the co-authorship network connecting the top 25 collaborators of Jan H. Marxsen. A scholar is included among the top collaborators of Jan H. Marxsen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan H. Marxsen. Jan H. Marxsen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
2.
Marxsen, Jan H., et al.. (2014). Development of a new clot formation protocol for standardized in vitro investigations of sonothrombolysis. Journal of Neuroscience Methods. 237. 26–32. 10 indexed citations
3.
Brüggemann, Norbert, et al.. (2012). Excessively increased CSF tau in progressive multifocal leukoencephalopathy. Clinical Neurology and Neurosurgery. 114(6). 762–764. 3 indexed citations
4.
Marxsen, Jan H., P. Weber, Florian Stellmacher, et al.. (2011). Introduction of a new model for time-continuous and non-contact investigations of in-vitro thrombolysis under physiological flow conditions. BMC Neurology. 11(1). 58–58. 5 indexed citations
5.
Marxsen, Jan H., et al.. (2011). The platelet-rich plasma clot. Blood Coagulation & Fibrinolysis. 22(5). 407–415. 21 indexed citations
6.
7.
Marxsen, Jan H., et al.. (2008). Prevalence of Platelet Dysfunction and Abnormal Coagulation: Results of a Population-Based Study. Clinical and Applied Thrombosis/Hemostasis. 15(4). 421–427. 3 indexed citations
8.
Dalhoff, Klaus, Jan H. Marxsen, & J. Steinhoff. (2007). Pneumonien bei Immunsuppression. Der Internist. 48(5). 507–518. 6 indexed citations
9.
Metzen, Eric, et al.. (2005). Regulation of the prolyl hydroxylase domain protein 2 (phd2/egln-1) gene: identification of a functional hypoxia-responsive element. Biochemical Journal. 387(3). 711–717. 165 indexed citations
10.
Hellwig‐Bürgel, Thomas, Daniel P. Stiehl, Dörthe M. Katschinski, et al.. (2005). VEGF Production by Primary Human Renal Proximal Tubular Cells: Requirement of HIF-1, PI3-Kinase and MAPKK-1 Signaling. Cellular Physiology and Biochemistry. 15(1-4). 99–108. 16 indexed citations
11.
Marxsen, Jan H., Pekka T. Heikkinen, Terhi Jokilehto, et al.. (2004). Hypoxia-inducible factor-1 (HIF-1) promotes its degradation by induction of HIF-α-prolyl-4-hydroxylases. Biochemical Journal. 381(3). 761–767. 303 indexed citations
12.
Metzen, Eric, Utta Berchner‐Pfannschmidt, Jan H. Marxsen, et al.. (2003). Intracellular localisation of human HIF-1α hydroxylases:implications for oxygen sensing. Journal of Cell Science. 116(7). 1319–1326. 356 indexed citations
13.
Marxsen, Jan H., Oliver Schmitt, Eric Metzen, Wolfgang Jelkmann, & Thomas Hellwig‐Bürgel. (2001). Vascular endothelial growth factor gene expression in the human breast cancer cell line MX-1 is controlled by O2 availability in vitro and in vivo. Annals of Anatomy - Anatomischer Anzeiger. 183(3). 243–249. 14 indexed citations
14.
Vogel, Ilka, Uwe Krüger, Jan H. Marxsen, et al.. (1999). Disseminated tumor cells in pancreatic cancer patients detected by immunocytology: a new prognostic factor.. PubMed. 5(3). 593–9. 63 indexed citations
15.
Soeth, Edlyn, Ilka Vogel, Christian Röder, et al.. (1997). Comparative analysis of bone marrow and venous blood isolates from gastrointestinal cancer patients for the detection of disseminated tumor cells using reverse transcription PCR.. PubMed. 57(15). 3106–10. 185 indexed citations
16.
Marxsen, Jan H., Wolff Schmiegel, Christian Röder, et al.. (1994). Detection of the anti-p53 antibody response in malignant and benign pancreatic disease. British Journal of Cancer. 70(5). 1031–1034. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jennifer A. Doll Breakdown of academic impact, for papers by Colleen Wu Breakdown of academic impact, for papers by Xianguo Kong Breakdown of academic impact, for papers by Betty Gardie Breakdown of academic impact, for papers by Xiao-Ping Zhou Breakdown of academic impact, for papers by Françoise Descôtes Breakdown of academic impact, for papers by Michael Fannon Breakdown of academic impact, for papers by Cara C. Bertozzi Breakdown of academic impact, for papers by Thomas Haberberger Breakdown of academic impact, for papers by Ariane Galaup
Rankless by CCL
2026